Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Shares Outstanding (Diluted Average) (2018 - 2025)

Historic Shares Outstanding (Diluted Average) for Organogenesis Holdings (ORGO) over the last 8 years, with Q3 2025 value amounting to $130.8 million.

  • Organogenesis Holdings' Shares Outstanding (Diluted Average) fell 229.81% to $130.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $130.8 million, marking a year-over-year decrease of 229.81%. This contributed to the annual value of $131.7 million for FY2024, which is 80.86% down from last year.
  • As of Q3 2025, Organogenesis Holdings' Shares Outstanding (Diluted Average) stood at $130.8 million, which was down 229.81% from $133.9 million recorded in Q2 2025.
  • Over the past 5 years, Organogenesis Holdings' Shares Outstanding (Diluted Average) peaked at $134.0 million during Q2 2021, and registered a low of $126.3 million during Q1 2025.
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $132.7 million (2022), whereas its average is $132.3 million.
  • As far as peak fluctuations go, Organogenesis Holdings' Shares Outstanding (Diluted Average) soared by 2795.57% in 2021, and later crashed by 422.12% in 2025.
  • Organogenesis Holdings' Shares Outstanding (Diluted Average) (Quarter) stood at $133.7 million in 2021, then decreased by 0.96% to $132.4 million in 2022, then rose by 0.27% to $132.7 million in 2023, then fell by 0.81% to $131.7 million in 2024, then fell by 0.63% to $130.8 million in 2025.
  • Its last three reported values are $130.8 million in Q3 2025, $133.9 million for Q2 2025, and $126.3 million during Q1 2025.